New York State Common Retirement Fund’s Insight Molecular Diagnostics IMDX Stock Holding History

New York State Common Retirement Fund’s Portfolio IMDX Stock Details IMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-29	Closed	-$1K	–	3397
2022 Q2	$1K	Sell	29 -1,775	-98%	-$40.4K	﹤0.01%	3382
2022 Q1	$54K	Hold	1,804	–	–	﹤0.01%	3153
2021 Q4	$78K	Sell	1,804 -7	-0.4%	-$403	﹤0.01%	3142
2021 Q3	$129K	Sell	1,811 -624	-26%	-$57.4K	﹤0.01%	3058
2021 Q2	$279K	Buy	2,435 +30	+1%	+$2.93K	﹤0.01%	2890
2021 Q1	$250K	Buy	2,405 +435	+22%	+$41.3K	﹤0.01%	2745
2020 Q4	$94K	Hold	1,970	–	–	﹤0.01%	3045
2020 Q3	$55K	Hold	1,970	–	–	﹤0.01%	3118
2020 Q2	$75K	Buy	1,970 +1,470	+294%	+$75.9K	﹤0.01%	3091
2020 Q1	$25K	Hold	500	–	–	﹤0.01%	3084
2019 Q4	$23K	Hold	500	–	–	﹤0.01%	3169
2019 Q3	$21K	Sell	500 -1,500	-75%	-$59K	﹤0.01%	3200
2019 Q2	$100K	Buy	+2,000	New	+$166K	﹤0.01%	3112
2018 Q2	–	Sell	-785	Closed	-$33K	–	3198
2018 Q1	$33K	Hold	785	–	–	﹤0.01%	3049
2017 Q4	$73K	Hold	785	–	–	﹤0.01%	3017
2017 Q3	$119K	Hold	785	–	–	﹤0.01%	2970
2017 Q2	$82K	Buy	+785	New	+$89.4K	﹤0.01%	3112
2016 Q2	–	Sell	-679	Closed	-$63K	–	3204
2016 Q1	$63K	Buy	+679	New	+$60.1K	﹤0.01%	3021

Other funds holding IMDX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

New York State Common Retirement Fund's IMDX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Insight Molecular Diagnostics (IMDX) in Q3 2022, closing a stake of 29 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in IMDX in Q1 2016 and held it in 18 quarters. The position peaked at $279K in Q2 2021. 65 funds tracked by Wall St. Rank hold IMDX as of Q3 2022.

New York State Common Retirement Fund reported no remaining Insight Molecular Diagnostics position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 29 Insight Molecular Diagnostics shares in Q3 2022, an estimated $1K.
New York State Common Retirement Fund first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 18 quarters.
New York State Common Retirement Fund's Insight Molecular Diagnostics position peaked at $279K in Q2 2021.
65 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.